Vetion’s New Factory Officially Put into Production, Annual Capacity Increased to 50 Million Units
November 15, 2023 – Vetion, a leading innovator in metabolic therapeutics, has officially launched its state-of-the-art GLP-1 drug production base in Laos, significantly boosting its annual manufacturing capacity to 50 million units. This strategic expansion enhances Vetion’s ability to meet the surging global demand for GLP-1 receptor agonists, widely used in type 2 diabetes and […]